DOCUSATE SODIUM

Posology Adults: 100mg (10ml) to 150mg (15ml) three times a day. Take as a single dose Treatment should be commenced with large doses, which should be decreased as the condition of the patient improves. For barium meals: 400mg (40ml) to be taken with the meal.

Elderly:

There is no evidence to suggest that an adjustment of the dosage is necessary in the elderly. 5mg/5ml. Method of administration Oral use

Frequencies are defined as follows:

Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data).

Gastrointestinal disorders:

Rare: diarrhoea, nausea, abdominal cramps Skin and subcutaneous tissue disorders: Not known: skin rash and pruritus. There have been spontaneous reports of burning sensation in mouth and throat following the use of Docusate sodium. Patients are advised to drink plenty of water or flavoured drink after taking the solution.

Reporting of suspected adverse reactions Reporting suspected adverse reaction after authorisation of the medicinal product is important. It allows continued monitoring of the benefit / risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Docusate sodium 50mg/5ml oral solution is not recommended for children aged 12 years and under. Organic disorders should be excluded prior to the administration of any laxative. The treatment of constipation with any medicinal product is only adjuvant to a healthy lifestyle and diet, for example: • increased intake of fluids and dietary fibre • advice on appropriate physical activity.

If laxatives are needed every day, or if there is persistent abdominal pain, consult your doctor. Prolonged use can precipitate the onset of an atonic non-functioning colon and hypokalaemia. Docusate sodium oral solution contains methyl parahydroxybenzoate and propyl parahydroxybenzoate.

May cause allergic reactions (possibly delayed). 0mg sodium benzoate in each 10ml dose. 0mg sorbitol in each 10ml dose. The additive effect of concomitantly administered products containing sorbitol (or fructose) and dietary intake of sorbitol (or fructose) should be taken into account.

The content of sorbitol in medicinal products for oral use may affect the bioavailability of other medicinal products for oral use administered concomitantly. Patients with hereditary fructose intolerance (HFI) should not be given this medicinal product.

9% of the WHO recommended maximum daily intake of 2g sodium for an adult.

1. • in the presence of abdominal pain, intestinal obstruction, nausea or if vomiting occurs.